Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.56415 | 72 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.53136 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.54598 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.26406 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.76046 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.43352 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.40706 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.52097 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.51378 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.51538 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.83188 | 74 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.51793 | 71 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.3001 | 69 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.83282 | 74 |